AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To be an Affirm Holdings shareholder, you need to believe the company can translate its growing merchant network, partnerships, and rapid product innovation into sustainable revenue and profitability, even as competitive and macroeconomic headwinds remain front and center. The recent shift to net income is meaningful, but the most critical near-term catalyst is Affirm’s merchant adoption and GMV growth, and this result does not materially reduce the risk from any potential loss of a major enterprise partner in the upcoming quarter.
Besides earnings, Affirm’s recently filed US$1.56 billion shelf registration for Class A Common Stock stands out. While not directly tied to its profitability, this filing could affect market sentiment regarding future capital needs, dilution, or share supply, and is relevant as the business seeks to maintain momentum and address evolving risks related to competitive positioning and funding costs.
By contrast, it’s crucial investors don’t overlook the specific risk that if Affirm’s integration with a major merchant partner ends soon, revenue...
Read the full narrative on Affirm Holdings (it's free!)
Affirm Holdings' outlook projects $6.0 billion in revenue and $756.6 million in earnings by 2028. This reflects a 22.9% annual revenue growth rate and a $704.4 million increase in earnings from current earnings of $52.2 million.
Uncover how Affirm Holdings' forecasts yield a $93.18 fair value, a 9% upside to its current price.
Seventeen Simply Wall St Community members estimate Affirm’s fair value anywhere from US$24.19 to US$195.17 per share. This broad diversity of opinion exists even as risks like the possible loss of a large merchant partner linger, shaping expectations for future growth and volatility.
Explore 17 other fair value estimates on Affirm Holdings - why the stock might be worth over 2x more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com